Coronavirus disease 2019 (COVID-19) has enabled scientists worldwide to identify new drugs or repurpose olde ones.1 Favipiravir (6-fluoro-3-hydroxy-2-pyrazinecarboxamide) is a broad-spectrum antiviral drug that inhibits RdRp of different RNA viruses and hinders the replication process. 1 This infographic will discuss the established efficacy and safety profile of favipiravir, a weapon to combat the ongoing pandemic.